PARLIAMENTARY WRITTEN QUESTION
Brain: Tumours (7 October 2024)

Question Asked

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of designating brain tumours as a clinical priority.

Asked by:
Sarah Green (Liberal Democrat)

Answer

While the Department has not made a formal assessment, it spends £1.5 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR), with cancer the largest area of spend at over £121.8 million in 2022/23 reflecting its high priority. In September 2024, the NIHR announced new research funding opportunities for brain cancer research spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure the most promising research opportunities are made available to adult and child patients and a new funding call to generate high quality evidence in brain tumour care, support and rehabilitation.

We will get the National Health Service diagnosing cancer, including brain tumours, on time, diagnosing it earlier and treating it faster so more patients survive this horrible set of diseases, and we will improve patients’ experience across the system. To do this, we will address the challenges in diagnostic waiting times, providing the number of computed tomography, magnetic resonance imaging and other tests that are needed to reduce cancer waits.


Answered by:
Andrew Gwynne (Labour)
10 October 2024

Contains Parliamentary information licensed under the Open Parliament Licence v3.0.